decisionhealth Newsletters, Answer Books - 2006 Issue 3 (March)
Program_Memos / 2000 / B-00-38
Subscribe or sign in to view the full article.
Article Overview
This HCFA/Medicare Program Memorandum addresses a claims-processing update for an oral anti-cancer drug source in the DMERC environment. It is relevant to billers, coders, and reimbursement staff who need to understand the administrative change, the systems affected, and the effective and implementation dates. The article also references the associated NDC identifiers and the Medicare coverage approval date for the drug source.
Why This Topic Matters
Organizations that process Medicare-related claims for durable medical equipment and related services may need to recognize the new internal identifiers and the systems they affect. The memo also provides timing information that can matter for historical reference, audits, and claims administration.
What You Will Learn
- What administrative change the memorandum announces
- Which Medicare-related systems are referenced
- The timing of the update and related coverage context
- How the memo frames the use of internal versus provider billing identifiers
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- DMEPOS/DMERC claims staff
- Compliance and reimbursement personnel
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com